ABSTRACT

Background: Prolonged grief disorder (PGD) is a chronic and disabling condition that affects approximately 10% of non-traumatically bereaved people. Narrative reconstruction (NR), originally designed for the treatment of posttraumatic stress disorder (PTSD), is a time-limited integrative therapy consisting of exposure to the loss memory, detailed written reconstruction of the loss memory narrative, and an elaboration of the personal significance of that memory for the bereaved.

Objective: This pilot study examined the efficacy of NR therapy in reducing symptoms in bereaved people diagnosed with PGD.

Method: Ten PGD patients participated in the study and were treated with 16 weekly sessions of NR. PGD, PTSD, and depression symptoms, as well as levels of loss integration, were assessed at pre-treatment, post-treatment, and at a 3-month follow-up.

Results: Following NR, participants showed significant reductions in PGD, depression, and PTSD symptoms, and elevated levels of trauma integration. Symptoms showed further improvement at the three-month follow-up.

Conclusions: These findings provide preliminary evidence for the feasibility and efficacy of NR in treating PGD. Narrative reconstruction therapy requires further evaluation in randomized controlled trials.

摘要

背景：长期悲伤障碍 (PGD) 是一种慢性致残性疾病，影响了大约 10% 的非创伤性丧亲者。叙事重建（NR），最初是为治疗创伤后应激障碍（PTSD）而设计的，是一种限时的综合疗法，包括暴露于丧失的记忆、详细的书面重建丧失记忆的叙述，以及对个人意义的阐述失去亲人的记忆。

目的：这项初步研究检查了 NR 疗法在减轻被诊断为 PGD 的丧亲者症状方面的疗效。

方法：10 名 PGD 患者参与了这项研究，并接受了 16 周的 NR 治疗。在治疗前、治疗后和 3 个月的随访中评估了 PGD、PTSD 和抑郁症状，以及丧失整合的水平。

结果：在 NR 之后，参与者的 PGD、抑郁和 PTSD 症状显着减少，创伤整合水平升高。症状在三个月的随访中进一步改善。

结论：这些发现为 NR 治疗 PGD 的可行性和有效性提供了初步证据。叙事重建疗法需要在随机对照试验中进一步评估。